Overall, our data provide motivation to better understand the tumor promotion and immune inhibition role of ALDH1A1/B1 in thyroid cancer patients, suggesting that ALDH1A1/B1 might serve as potential prognostic biomarkers for thyroid cancer treatment. The gene discussed is ALDH1A1; the disease is thyroid gland carcinoma.